MONTANOVA CAPITAL, LLC
SEC Form 4 insider trading activity
MONTANOVA CAPITAL, LLC has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, MONTANOVA CAPITAL, LLC is listed as Director at Veradermics, Inc. Inside the rolling window, MONTANOVA CAPITAL, LLC reported no open-market purchases and 1 open-market sale totaling $80.4M in MANE.
Companies traded
Other insiders at MANE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$80.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MONTANOVA CAPITAL, LLC made?
MONTANOVA CAPITAL, LLC has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does MONTANOVA CAPITAL, LLC trade?
MONTANOVA CAPITAL, LLC has filed SEC Form 4 disclosures for 1 company, including MANE.
When was MONTANOVA CAPITAL, LLC's most recent SEC Form 4 filing?
MONTANOVA CAPITAL, LLC's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is MONTANOVA CAPITAL, LLC's total buy and sell value in the current window?
Inside the rolling retention window, MONTANOVA CAPITAL, LLC bought $0 and sold $80.4M based on SEC Form 4 filings.
What was MONTANOVA CAPITAL, LLC's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 750,000 MANE shares on 2026-08-19, worth $80.4M, per SEC Form 4 filings.